The company said revenue for fiscal 2026 Q1 rose to $64.0 billion from $52.3 billion a year earlier, an increase of 22%. GAAP operating earnings increased 18% to $668 million.

1. 01

   The company said revenue for fiscal 2026 Q1 rose to $64.0 billion from $52.3 billion a year earlier, an increase of 22%. GAAP operating earnings increased 18% to $668 million.

2. 02

   Cardinal Health said non-GAAP operating earnings for Q1 rose 37% to $857 million, and non-GAAP diluted EPS increased 36% to $2.55. It attributed the gain to higher non-GAAP operating earnings, a lower share count and a lower effective tax rate, which were partly offset by higher interest and other expense from financing costs tied to the acquisitions.

3. 03

   The company raised its non-GAAP diluted EPS outlook for fiscal 2026 to $9.65 to $9.85 from the prior range of $9.30 to $9.50. It also raised its adjusted free cash flow outlook to $3.0 billion to $3.5 billion from the prior range of $2.75 billion to $3.25 billion.

4. 04

   The company reported net cash provided by operating activities of $973 million for Q1, compared with a use of $1,647 million a year earlier. It said non-GAAP adjusted free cash flow was $1,269 million, compared with a use of $1,361 million a year earlier.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.